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Summary {#efs25197-sec-0001}
=======

Following a request from the European Commission, the Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) was asked to deliver a scientific opinion on safety and efficacy of zinc‐[l]{.smallcaps}‐selenomethionine (Zn‐[l]{.smallcaps}‐SeMet) for all animal species.

The additive, 'Zinc‐[l]{.smallcaps}‐selenomethionine' (Zn‐[l]{.smallcaps}‐SeMet) is intended to be used as a source of selenium for all animal species. The preparation to be marketed is a blend of the active compound with inert carriers (in this assessment called as 'formulated additive'; trade name: Availa^®^Se).

Conclusions on the safety of an additive for target species are generally based on the absence of adverse effects in a tolerance study. No such effects were seen (i) in the zootechnical endpoints for the additive under assessment and the already authorised inorganic sodium selenite, also by comparison with the unsupplemented control diet and (ii) in most haematology and serum biochemistry parameters (the few exceptions were of statistical nature as well as unclear biological relevance, if any). The response of selenium serum levels and glutathione peroxidase (GPx) activity to dietary Zn‐[l]{.smallcaps}‐SeMet indicates selenium bioavailability. It is therefore concluded that the Zn‐[l]{.smallcaps}‐SeMet is a safe source of selenium for chickens for fattening. The conclusion is extended to all animal species.

Selenium from Zn‐[l]{.smallcaps}‐SeMet does not elicit any adverse effects not expected for a selenium compound. The use of Zn‐[l]{.smallcaps}‐SeMet in animal nutrition is expected to result in a similar increase in selenium deposition in animal tissues/products as that resulting from other sources of SeMet. The use of the additive is safe for consumers provided that the maximum selenium supplementation level established for other sources of organic selenium (0.2 mg/kg complete feed) and that the maximum authorised total selenium content (0.5 mg/kg complete feed) are respected.

The additive is hazardous upon inhalation; owing to the high dusting potential, persons handling Availa^®^Se are at risk by inhalation. Availa^®^Se is not an irritant to the skin. In the absence of data, no conclusion on the eye irritation and skin sensitisation can be drawn.

The use of Zn‐[l]{.smallcaps}‐SeMet in feed does not pose an additional risk to the environment, compared with other sources of selenium for which it will substitute, as long as the maximum authorised content in complete feed is not exceeded.

Zn‐[l]{.smallcaps}‐SeMet is an effective source of selenium in chickens for fattening and laying hens; this conclusion is extended to all animal species.

The maximum contribution of zinc in total feed deriving from the use of the additive (\< 0.2 mg Zn/kg feed) is considered low and does not need any safety assessment except for users.

The FEEDAP Panel recommends to use the additive in compound feed via premixtures.

1. Introduction {#efs25197-sec-0003}
===============

1.1. Background and Terms of Reference {#efs25197-sec-0004}
--------------------------------------

Regulation (EC) No 1831/2003[1](#efs25197-note-1006){ref-type="fn"} establishes the rules governing the Community authorisation of additives for use in animal nutrition. In particular, Article 4(1) of that Regulation lays down that any person seeking authorisation for a feed additive or for a new use of a feed additive shall submit an application in accordance with Article 7.

The European Commission received a request from Zinpro Animal Nutrition (Europe), Inc.[2](#efs25197-note-1007){ref-type="fn"} for authorisation of the product zinc [l]{.smallcaps}‐selenomethionine, when used as a feed additive for all animal species (category: nutritional additives; functional group: compounds of trace elements).

According to Article 7(1) of Regulation (EC) No 1831/2003, the Commission forwarded the application to the European Food Safety Authority (EFSA) as an application under Article 4(1) (authorisation of a feed additive or new use of a feed additive). EFSA received directly from the applicant the technical dossier in support of this application. The particulars and documents in support of the application were considered valid by EFSA as of 24 October 2016.

According to Article 8 of Regulation (EC) No 1831/2003, EFSA, after verifying the particulars and documents submitted by the applicant, shall undertake an assessment in order to determine whether the feed additive complies with the conditions laid down in Article 5. EFSA shall deliver an opinion on the safety for the target animals, consumer, user and the environment and on the efficacy of the product zinc [l]{.smallcaps}‐selenomethionine, when used under the proposed conditions of use (see Section [3.1.6](#efs25197-sec-0016){ref-type="sec"}).

1.2. Additional information {#efs25197-sec-0005}
---------------------------

Zinc‐[l]{.smallcaps}‐selenomethionine (Zn‐[l]{.smallcaps}‐SeMet) is intended to be used as a source of selenium for all animal species. The additive has not been previously authorised as a feed additive in the European Union (EU).

The applicant holds a patent on the Zn‐[l]{.smallcaps}‐SeMet, with the title 'Derivatives of seleno‐amino acids with improved bioavailability and method for assuring adequate dietary requirements of selenium for livestock'.[3](#efs25197-note-1008){ref-type="fn"} The primary objective of the invention was the development of new compounds intended to enhance the bioavailability and/or increase the stability of seleno‐amino acids.

In 2014, the Food and Drug Administration (FDA) announced that Zinpro Corp. filed a petition proposing that the food additive regulations be amended to provide for the safe use of Zn‐[l]{.smallcaps}‐SeMet as a source of selenium in complete feed for broiler chickens.[4](#efs25197-note-1009){ref-type="fn"}

2. Data and methodologies {#efs25197-sec-0006}
=========================

2.1. Data {#efs25197-sec-0007}
---------

The present assessment is based on data submitted by the applicant in the form of a technical dossier[5](#efs25197-note-1010){ref-type="fn"} in support of the authorisation request for the use of Zn‐[l]{.smallcaps}‐SeMet as a feed additive for all animal species. The technical dossier was prepared following the provisions of Article 7 of Regulation (EC) No 1831/2003, Regulation (EC) No 429/2008[6](#efs25197-note-1011){ref-type="fn"} and the applicable EFSA guidance documents.

The FEEDAP Panel used the data provided by the applicant together with data from other sources, such as previous risk assessments by EFSA or other expert bodies, peer‐reviewed scientific papers and other scientific reports, to deliver the present output.

EFSA has verified the EURL report as it relates to the methods used for the control of Zn‐[l]{.smallcaps}‐SeMet in animal feed. The Executive Summary of the EURL report can be found in Annex [A](#efs25197-sec-1001){ref-type="sec"}.[7](#efs25197-note-1012){ref-type="fn"}

2.2. Methodologies {#efs25197-sec-0008}
------------------

The approach followed by the FEEDAP Panel to assess the safety and the efficacy of Zn‐[l]{.smallcaps}‐Se‐Met is in line with the principles laid down in Regulation (EC) No 429/2008[6](#efs25197-note-1011){ref-type="fn"} and the relevant guidance documents: Guidance on nutritional additives (EFSA FEEDAP Panel, [2012a](#efs25197-bib-0013){ref-type="ref"}), Technical guidance: Tolerance and efficacy studies in target animals (EFSA FEEDAP Panel, [2011a](#efs25197-bib-0010){ref-type="ref"}), Technical Guidance for assessing the safety of feed additives for the environment (EFSA, [2008](#efs25197-bib-0008){ref-type="ref"}), Guidance for establishing the safety of additives for the consumer (EFSA FEEDAP Panel, [2012b](#efs25197-bib-0014){ref-type="ref"}) and Guidance on studies concerning the safety of use of the additive for users/workers (EFSA FEEDAP Panel, [2012c](#efs25197-bib-0015){ref-type="ref"}).

3. Assessment {#efs25197-sec-0009}
=============

The active compound under assessment is the Zn‐[l]{.smallcaps}‐SeMet. The preparation to be marketed is a blend of the active compound with inert carriers (in this assessment called as 'formulated additive'; trade name: Availa^®^Se 1000). It is intended to supply selenium as nutritional element to all animal species.

3.1. Characterisation {#efs25197-sec-0010}
---------------------

### 3.1.1. Characterisation of the compound {#efs25197-sec-0011}

The additive is 'Zinc‐[l]{.smallcaps}‐Selenomethionine'. Another generic international name is also (*S*)‐(+)‐2‐amino‐4‐(methylseleno)butanoic acid. It has neither a Chemical Abstracts Service (CAS) number nor an International Union of Pure and Applied Chemistry (IUPAC) name. Its chemical formula is C~5~H~10~ClNO~2~SeZn, the structural formula is shown in Figure [1](#efs25197-fig-0001){ref-type="fig"} and it has a molecular weight of 295.94 Da. The theoretical content of selenium is 26.7% and of zinc of 22.1%.

![Structural Formula of zinc‐[l]{.smallcaps}‐selenomethionine (taken from Zinpro Patent Number EP 1594365 A1)](EFS2-16-e05197-g001){#efs25197-fig-0001}

The molecular structure of the active compound was characterised in three lots by infrared and proton nuclear magnetic resonance spectroscopies.[8](#efs25197-note-1013){ref-type="fn"}

The active compound is not available from the synthesis as such (purified), but together with hydrochloric acid (see Section [3.1.3](#efs25197-sec-0013){ref-type="sec"}). Five batches of the reaction product were analysed for selenomethionine (SeMet), total selenium, zinc and chloride.[9](#efs25197-note-1014){ref-type="fn"} The average content of SeMet was about 63.6%, selenium 25.6%, zinc 20% and chloride 21.3%

The same five batches were analysed for undesirable substances.[10](#efs25197-note-1015){ref-type="fn"} Levels of heavy metals (Cd \< 1 mg/kg compound[11](#efs25197-note-1016){ref-type="fn"}; Pb \< 1 mg/kg compound;^8^ Hg \< 0.1 mg/kg compound), F (\< 25 mg/kg compound) and As (\< 1 mg/kg compound) were reported. The levels of dioxins and the sum of dioxins and dioxin‐like PCBs were 0.13--0.18 ng WHO‐PCDD/F‐TEQ/kg and 0.18--0.23 ng WHO‐PCDD/F‐PCB‐TEQ/kg, respectively. The concentrations of the undesirable substances analysed comply with those set in Directive 2002/32/EC[12](#efs25197-note-1017){ref-type="fn"} for compounds of trace elements or, if not mentioned in the Directive, do not represent a concern.

### 3.1.2. Characterisation of the formulated additive {#efs25197-sec-0012}

The formulated additive is a solid preparation with a light grey to tan colour and no odour. The relative density is 2.9. It is very slightly soluble in water.[13](#efs25197-note-1018){ref-type="fn"} The bulk density, measured in three samples, ranged between 1.39 and 1.41 g/cm^3^.

As formulated, Zn‐[l]{.smallcaps}‐SeMet provides a minimum of selenium and SeMet of 1,000 and 2,500 mg/kg additive, respectively.

The composition of the formulated additive is: 97.0% of calcium carbonate, 1.62% of silicon dioxide, 1.02% of vegetable oil and 0.36% of Zn‐[l]{.smallcaps}‐SeMet.

Five batches of the formulated additive were analysed for zinc, selenium and SeMet.[14](#efs25197-note-1019){ref-type="fn"} Zinc content ranged from 875 to 910 mg/kg; total selenium content from 1,041 to 1,157 and SeMet from 2,530 to 2,751 mg/kg, thus meeting the specifications. The ratio between zinc and selenium is about 0.82.

Six batches were analysed for undesirable substances, except for fluorine in which results for only four batches were reported.[15](#efs25197-note-1020){ref-type="fn"} Levels of heavy metals (Cd: 0.16 to \< 1 mg/kg additive[16](#efs25197-note-1021){ref-type="fn"}; Pb: 1.18--2.17 mg/kg additive; Hg: \< 0.05--\< 0.1 mg/kg additive),[13](#efs25197-note-1018){ref-type="fn"} F (16.6--66.5 mg/kg additive[13](#efs25197-note-1018){ref-type="fn"}) and As (\< 0.1--1.16 mg/kg additive) were reported. The levels of dioxins and the sum of dioxins and dioxin‐like PCBs were 0.044--0.089 ng WHO‐PCDD/F‐TEQ per kg and 0.10--0.14 ng WHO‐PCDD/F‐PCB‐TEQ per kg, respectively. The concentrations of the undesirable substances analysed comply with those set in Directive 2002/32/EC for compounds of trace elements or, if not mentioned in the Directive, do not represent a concern.

Analysis of five batches (aged from 2 weeks to 10 months) confirmed the absence of microbial contamination. Counts of Enterobacteriaceae, moulds and yeasts were below the limit of quantification (LOQ) (\< 10 cfu/g); *Salmonella* was not detected in 25 g.[17](#efs25197-note-1022){ref-type="fn"} Levels of aflatoxin B1 and ochratoxin A analysed in three batches were below the LOQ (4 μg/kg).[18](#efs25197-note-1023){ref-type="fn"} ^,^ [19](#efs25197-note-1024){ref-type="fn"}

Analysis of the particle size distribution (v/v) by laser diffraction (three batches) showed that 1.1--4.1% of the particles had a diameter \< 10 μm, 3.2--12.4% \< 50 μm and 13.1--27.2% \< 100 μm.[20](#efs25197-note-1025){ref-type="fn"}

Dusting potential was analysed in three batches by the Stauber--Heubach method (four measurements of each batch).[21](#efs25197-note-1026){ref-type="fn"} The values reported were in the range of 6.1--11.0 g/m^3^. The same batches were submitted for analysis of the particle size and the zinc and selenium content (two measurements per batch) of the dust.[22](#efs25197-note-1027){ref-type="fn"} The results showed that on average 93% of the particles were below 10 μm; zinc ranged from 3,458 to 7,901 mg/kg dust[23](#efs25197-note-1028){ref-type="fn"} and selenium from 3,307 to 5,833 mg/kg dust. These data show that there is an enrichment of the zinc and selenium in the dust compared with the additive, likely due to the finer particles in the active compound compared to the other components of the additive.

### 3.1.3. Manufacturing process[24](#efs25197-note-1029){ref-type="fn"} {#efs25197-sec-0013}

The additive is produced by complexing [l]{.smallcaps}‐SeMet (from chemical synthesis)[19](#efs25197-note-1024){ref-type="fn"} with zinc to form Zn‐[l]{.smallcaps}‐SeMet complex. The manufacturing process of the active compound and of the formulated additive are described in the technical dossier.

### 3.1.4. Stability and homogeneity {#efs25197-sec-0014}

For compounds of trace elements, stability studies are generally not required. The applicant proposed for the formulated additive a shelf‐life of 24 months. Two stability studies with three batches each under ambient (25°C/60% relative humidity (RH)) and accelerated (40°C/75% RH) conditions were on‐going at the time of the assessment, monitoring SeMet content.[25](#efs25197-note-1030){ref-type="fn"} Only values up to 3 months were made available. The SeMet content decreased after 3 months storage under ambient conditions from 3,370 to 3,073 mg (91.2%) and under accelerated conditions to 2,763 mg (82.0%) per kg formulated additive.

A stability study of the additive in premixtures and mash feed monitoring selenium was provided.[26](#efs25197-note-1031){ref-type="fn"} This study is part of the efficacy study submitted (see also Section [3.3.1](#efs25197-sec-0033){ref-type="sec"}). After about 9 months of storage, a recovery of 98.5% and 93.3% was reported for premixture and mash feed, respectively. The FEEDAP Panel notes that in this study the identified main active substance, i.e. SeMet, was not quantified.

The capacity of the additive to homogeneously distribute in premixtures[27](#efs25197-note-1032){ref-type="fn"} and complete feed (mash and pelleted)[28](#efs25197-note-1033){ref-type="fn"} was investigated, analysing the selenium content in 10 subsamples each. The coefficient of variation (CV) of the selenium concentration in the premixture (mean 289 mg/kg) was 7.4%. The CV of the mash feed (mean selenium content: 0.195 mg/kg) was 3.0%, that of the same feed after pelleting 3.3%.

### 3.1.5. Physicochemical incompatibilities or interactions {#efs25197-sec-0015}

No incompatibilities resulting from the use of Zn‐L‐SeMet in compound feed are expected with the feed materials, carriers, other approved additives or medicinal products.

### 3.1.6. Conditions of use {#efs25197-sec-0016}

The additive is intended to be used in feed for all animal species. It should be used up to a maximum supplementation rate of 0.2 mg Se/kg feed; a total selenium concentration of 0.5 mg/kg feed should not be exceeded. The additive should be incorporated to feed via a premixture.

3.2. Safety {#efs25197-sec-0017}
-----------

### 3.2.1. Absorption, distribution, metabolism and excretion (ADME) {#efs25197-sec-0018}

No specific studies on the toxicokinetics of Zn‐[l]{.smallcaps}‐SeMet were provided. It can reasonably be assumed that the zinc moiety is dissociated in the intestine (see also Section [3.3](#efs25197-sec-0032){ref-type="sec"}). Taking into account the conditions of use of the additive, the content of zinc is negligible and will not be further considered (see also Section [3.1.6](#efs25197-sec-0016){ref-type="sec"}).[29](#efs25197-note-1034){ref-type="fn"} Consequently, SeMet is the only relevant fraction. The ADME of [l]{.smallcaps}‐SeMet, including its hydroxy‐analogue and the [dl]{.smallcaps}‐form, has been described in previous EFSA FEEDAP opinions (EFSA, [2006](#efs25197-bib-0007){ref-type="ref"}, [2009](#efs25197-bib-0009){ref-type="ref"}; EFSA FEEDAP Panel, [2011b](#efs25197-bib-0011){ref-type="ref"},[c](#efs25197-bib-0012){ref-type="ref"}; EFSA FEEDAP Panel, [2013a](#efs25197-bib-0018){ref-type="ref"},[b](#efs25197-bib-0019){ref-type="ref"}, [2014a](#efs25197-bib-0020){ref-type="ref"}). Ingested SeMet is actively absorbed in the gut like methionine, the sulfur analogue of SeMet (Schrauzer, [2000](#efs25197-bib-0801){ref-type="ref"}); a common Na^+^ dependent transport mechanism of SeMet and Met in the jejunal brush border membrane of pigs was shown as early as in 1989 (Wolffram et al., [1989](#efs25197-bib-0036){ref-type="ref"}); rapid distribution of the absorbed SeMet occurs in most organs (Alexander, [2015](#efs25197-bib-0002){ref-type="ref"}). SeMet is non‐specifically incorporated into body proteins as a substitute for the common amino acid Met (Schrauzer, [2000](#efs25197-bib-0801){ref-type="ref"}); it can act as a selenium reservoir for the organism. Another portion of SeMet is metabolised resulting into dihydrogen selenide to be utilised in selenium pathways. Urine is the major excretory pathway of selenium (Alexander, [2015](#efs25197-bib-0002){ref-type="ref"}).

### 3.2.2. Toxicological studies {#efs25197-sec-0019}

No specific toxicological studies for the product under assessment were provided by the applicant.

Considering the contribution of zinc by the highest supplementation of the additive, any exposure from zinc from the additive is considered toxicologically negligible. The Met from the additive will be incorporated in body proteins or completely metabolised (EFSA FEEDAP Panel, [2012d](#efs25197-bib-0016){ref-type="ref"}). Both components are therefore not considered a toxicological concern.

The toxicology of selenium, including organic forms, namely SeMet, has been extensively reviewed by the Scientific Committee on Food (SCF) (European Commission, [2000](#efs25197-bib-0027){ref-type="ref"}), the Agency for Toxic Substances and Disease Registry (ATSDR, [2003](#efs25197-bib-0003){ref-type="ref"}), the WHO ([2011](#efs25197-bib-0035){ref-type="ref"}), the European Medicines Agency (EMA, [2015](#efs25197-bib-0026){ref-type="ref"}) and the FEEDAP Panel (EFSA, [2006](#efs25197-bib-0007){ref-type="ref"}, [2009](#efs25197-bib-0009){ref-type="ref"}; EFSA FEEDAP Panel, [2011b](#efs25197-bib-0011){ref-type="ref"},[c](#efs25197-bib-0012){ref-type="ref"}, [2013a](#efs25197-bib-0018){ref-type="ref"},[b](#efs25197-bib-0019){ref-type="ref"}, [2014a](#efs25197-bib-0020){ref-type="ref"},b, [2015](#efs25197-bib-0022){ref-type="ref"}, [2016a](#efs25197-bib-0023){ref-type="ref"},[b](#efs25197-bib-0024){ref-type="ref"}).

Briefly, selenium excess (selenosis) is a well‐known disease in humans and animals. Although selenium may induce oxidative DNA damage *in vitro*, genotoxic effects could be shown *in vivo* only when toxic doses (\> 3 mg Se/kg body weight (bw)) were applied (European Commission, [2000](#efs25197-bib-0027){ref-type="ref"}). Teratogenic effects occur at high doses in birds (\> 3 mg Se (as SeMet)/kg diet; Spallholz and Hoffman, [2002](#efs25197-bib-0031){ref-type="ref"}) and fishes (\> 10 mg Se/kg diet; Lemly, [2002](#efs25197-bib-0028){ref-type="ref"}); however, developmental toxicity in mammals is controversial (EMA, [2015](#efs25197-bib-0026){ref-type="ref"}). Endocrine‐disrupting effects targeting thyroid, growth hormone and insulin‐like growth factor, have been described in humans (Maggio et al., [2010](#efs25197-bib-0029){ref-type="ref"}; Valdiglesias et al., 2010) and in mice (Ren et al., [2016](#efs25197-bib-0030){ref-type="ref"}); however, such effects are reversible in adult individuals upon discontinuation of exposure.

The FEEDAP Panel considers that selenium supplementation using the additive Zn‐[l]{.smallcaps}‐SeMet does not introduce any different toxicological concerns compared to other organic sources of selenium.

### 3.2.3. Safety for the target species {#efs25197-sec-0020}

#### 3.2.3.1. Safety for target species {#efs25197-sec-0021}

Where a feed additive application is made as a nutritional additive for all animal species, tolerance data may be limited to one species. The applicant provided a tolerance study with Zn‐[l]{.smallcaps}‐SeMet (Availa^®^Se) in chickens for fattening with duration of 36 days.[30](#efs25197-note-1035){ref-type="fn"} ^,^ [31](#efs25197-note-1036){ref-type="fn"}

A total of 1,200 one‐day‐old male broiler chickens (Ross 308) were allocated to five treatment groups in a randomised complete block design. Each treatment had 12 replicates (pens) containing 20 birds each. The treatments consisted of a negative control (starter and grower feeds containing 0.04 and 0.07 mg Se/kg, respectively), two groups with added sodium selenite (0.2 and 2.0 mg Se/kg) and two treatments with added Zn‐[l]{.smallcaps}‐SeMet (0.2 and 2.0 mg Se/kg). The birds did not receive any medical treatment during the trial.

All chickens were fed *ad libitum* a pelleted feed (starter/grower). The diets were mainly composed of wheat, maize and soybean meal and contained as a starter (day 1--21) 21.0% crude protein (CP) and 12.1 MJ AME/kg and as grower (from day 22 onwards) 19.6% CP and 12.5 MJ AME/kg. Final feeds were analysed for nutritional composition, energy and selenium concentration.

The birds were inspected at least once a day for general health. Mortality was daily monitored. Body weight was measured at the end of the starter period (day 21) and at the end of the study (day 36), feed intake was recorded for both periods. Body weight gain and feed to gain ratio were calculated for the corresponding intervals. Blood samples were taken from two birds per pen on day 36 (haematology,[32](#efs25197-note-1037){ref-type="fn"} clinical biochemistry[33](#efs25197-note-1038){ref-type="fn"}) and on day 37 (selenium, glutathione peroxidase (GPx) for the treatments without selenium supplementation and with 0.2 mg Se from both sources/kg feed). GPx was analysed on the individual samples, selenium on pooled pen samples. The birds used for blood collection on day 36 were subsequently killed; samples of liver, kidney, muscle tissue (left breast) and skin plus fat of the control group and of the groups with feed supplemented with 0.2 mg Se/kg were taken for tissue analysis (pooled samples per pen). Neither macroscopic nor microscopic examination of organs and tissues was made at necropsy.

The data were subjected to analysis of variance (ANOVA) considering blocks and treatments as variables. Treatments were compared by the least significant differences (LSD) test after significant effects had been confirmed by ANOVA. Differences with a p value ≤ 0.05 were considered significant, based on a two‐sided test. The pen was the statistical unit for the zootechnical parameters and the pooled selenium levels in serum and tissues, and the individual bird for other blood parameters.

No adverse health effects were seen. At the end of the study, there were no significant differences between the groups for body weight gain, feed to gain ratio and mortality (Table [1](#efs25197-tbl-0001){ref-type="table"}). The haematological endpoints were not significantly different (except the monocytes, which were lower at the 0.2 mg Se from Zn‐[l]{.smallcaps}‐Se‐Met than for all other groups; Table [2](#efs25197-tbl-0002){ref-type="table"}). Concerning blood biochemistry, the only significant differences were seen for alkaline phosphatase (ALP) and calcium (see Table [2](#efs25197-tbl-0002){ref-type="table"}). ALP increased in the Zn‐[l]{.smallcaps}‐SeMet groups, the value for the high dose being significantly different to the control; both selenite groups did not differ from the control. Calcium was significantly higher in the high selenium Zn‐L‐SeMet group compared to the two 0.2 mg Se/kg groups. The GPx levels in serum were significantly higher in the two selenium supplemented groups (only the 0.2 mg Se supplementation groups analysed) without differences between the selenium sources. The supplemented birds had a 30 fold increase in GPx activity, whereas the increase in serum selenium was only five‐ to sixfold (see Section [3.3](#efs25197-sec-0032){ref-type="sec"}). Selenium in serum was highest in the Zn‐[l]{.smallcaps}‐SeMet group, followed by the sodium selenite group with lowest levels in the control group. GPx activity is considered as a biomarker of selenium bioavailability, and the observed increase, together with elevated selenium serum levels, indicates selenium bioavailability from Zn‐[l]{.smallcaps}‐SeMet. The few other differences seen in haematology and serum biochemistry parameters were, if any, of unclear biological relevance.

###### 

Effects of various dosages of sodium selenite and zinc‐[l]{.smallcaps}‐selenomethionine (Availa^®^Se) on performance of chickens for fattening (day 36) (240 birds per treatment)

  Selenium supplemented (mg/kg)                               0                                                                                           Na‐selenite                                                                                 Availa^®^Se                                                                                       
  ----------------------------------------------------------- ------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------- ------------------------------------------------ ------------------------------------------------ ------------------------------------------------
  Selenium content[^1^](#efs25197-note-0006){ref-type="fn"}                                                                                                                                                                                                                                                                                             
  Starter diet                                                0.04                                                                                        0.23                                                                                        2.04                                             0.29                                             2.26
  Grower diet                                                 0.07                                                                                        0.27                                                                                        2.13                                             0.33                                             2.51
  Mortality (%)                                               4.6                                                                                         4.6                                                                                         5.7                                              3.4                                              8.4
  Feed intake (g/bird)                                        3,847[^a^](#efs25197-note-0007){ref-type="fn"}, [^b^](#efs25197-note-0007){ref-type="fn"}   3,834[^a^](#efs25197-note-0007){ref-type="fn"}, [^b^](#efs25197-note-0007){ref-type="fn"}   3,753[^a^](#efs25197-note-0007){ref-type="fn"}   3,914[^b^](#efs25197-note-0007){ref-type="fn"}   3,800[^a^](#efs25197-note-0007){ref-type="fn"}
  Body weight gain (g/bird)                                   2,683                                                                                       2,734                                                                                       2,661                                            2,782                                            2,730
  Feed to gain ratio (kg/kg)                                  1.434                                                                                       1.403                                                                                       1.412                                            1.407                                            1.392

1 Analysed (mg/kg).

a,b Different superscripts within a given row indicate statistical differences (p \< 0.05).

John Wiley & Sons, Ltd

###### 

Effects of various dosages of sodium selenite and zinc‐[l]{.smallcaps}‐selenomethionine (Availa^®^Se) on haematology and biochemistry parameters of chickens for fattening (day 36) (24 birds per treatment)

  Selenium supplemented (mg/kg)            0                                                                                           Na‐selenite                                                                                 Availa^®^Se                                                                                                                                                                            
  ---------------------------------------- ------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------- ------------------------------------------------
  Monocytes (10^9^/L)                      0.09[^b^](#efs25197-note-0009){ref-type="fn"}                                               0.07[^a^](#efs25197-note-0009){ref-type="fn"}, [^b^](#efs25197-note-0009){ref-type="fn"}    0.09[^b^](#efs25197-note-0009){ref-type="fn"}                                              0.02[^a^](#efs25197-note-0009){ref-type="fn"}                                               0.10[^b^](#efs25197-note-0009){ref-type="fn"}
  Alkaline phosphatase (IU/L)              4,951[^a^](#efs25197-note-0009){ref-type="fn"}, [^b^](#efs25197-note-0009){ref-type="fn"}   4,920[^a^](#efs25197-note-0009){ref-type="fn"}, [^b^](#efs25197-note-0009){ref-type="fn"}   4,416[^a^](#efs25197-note-0009){ref-type="fn"}                                             6,142[^b^](#efs25197-note-0009){ref-type="fn"}, [^c^](#efs25197-note-0009){ref-type="fn"}   7,252[^c^](#efs25197-note-0009){ref-type="fn"}
  Calcium (mmol/L)                         2.59[^b^](#efs25197-note-0009){ref-type="fn"}                                               2.45[^a^](#efs25197-note-0009){ref-type="fn"}                                               2.49[^a^](#efs25197-note-0009){ref-type="fn"}, [^b^](#efs25197-note-0009){ref-type="fn"}   2.45[^a^](#efs25197-note-0009){ref-type="fn"}                                               2.60[^b^](#efs25197-note-0009){ref-type="fn"}
  Glutathione peroxidase in serum (U/mL)   48[^a^](#efs25197-note-0009){ref-type="fn"}                                                 1,448[^b^](#efs25197-note-0009){ref-type="fn"}                                              ND[^1^](#efs25197-note-0008){ref-type="fn"}                                                1,414[^b^](#efs25197-note-0009){ref-type="fn"}                                              ND

1 ND: Not Determined.

a,b,c Different superscripts within a given row indicate statistical differences (p* *\< 0.05).

John Wiley & Sons, Ltd

#### 3.2.3.2. Conclusions on safety for the target species {#efs25197-sec-0022}

Conclusions on the safety of an additive for target species are generally based on the absence of adverse effects in a tolerance study. No such effects were seen (i) in the zootechnical endpoints for the additive under assessment and the already authorised inorganic sodium selenite, also by comparison with the unsupplemented control diet and (ii) in most haematology and serum biochemistry parameters (the few exceptions were of statistical nature as well as unclear biological relevance, if any). The response of selenium serum levels and GPx activity to dietary Zn‐[l]{.smallcaps}‐SeMet indicates selenium bioavailability. It is therefore concluded that the Zn‐[l]{.smallcaps}‐SeMet is a safe source of selenium for chickens for fattening. The conclusion is extended to all animal species.

### 3.2.4. Safety for the consumer {#efs25197-sec-0023}

#### 3.2.4.1. Deposition studies {#efs25197-sec-0024}

Deposition data in tissues and eggs were taken from the tolerance study in chickens for fattening (described in Section [3.2.3.1](#efs25197-sec-0021){ref-type="sec"}) and from an efficacy study in laying hens (described in Section [3.3.2](#efs25197-sec-0034){ref-type="sec"}). Results of the negative control, the group with sodium selenite at 0.2 mg/kg and the group with Zn‐[l]{.smallcaps}‐SeMet at 0.2 mg/kg are reported in Table [3](#efs25197-tbl-0003){ref-type="table"}.

###### 

Data on tissue and egg deposition of sodium selenite and zinc‐[l]{.smallcaps}‐selenomethionine (Availa^®^Se) from a study in chickens for fattening (day 36) (24 birds per treatment) and a study in laying hens (day 59)

  Selenium supplemented (mg/kg)                                    0                                                Na‐selenite                                    Availa^®^Se                                    Ratio Se from Availa^®^Se to Se from Na‐selenite
  ---------------------------------------------------------------- ------------------------------------------------ ---------------------------------------------- ---------------------------------------------- --------------------------------------------------
  Selenium content in:                                                                                                                                                                                            
  Breast muscle (ng/g)                                             100[^a^](#efs25197-note-0012){ref-type="fn"}     103[^a^](#efs25197-note-0012){ref-type="fn"}   265[^b^](#efs25197-note-0012){ref-type="fn"}   2.57
  Liver (ng/g)                                                     250[^a^](#efs25197-note-0012){ref-type="fn"}     513[^b^](#efs25197-note-0012){ref-type="fn"}   655[^c^](#efs25197-note-0012){ref-type="fn"}   1.27
  Kidney (ng/g)                                                    253[^a^](#efs25197-note-0012){ref-type="fn"}     695[^b^](#efs25197-note-0012){ref-type="fn"}   809[^c^](#efs25197-note-0012){ref-type="fn"}   1.16
  Skin/fat (ng/g)                                                  79[^a^](#efs25197-note-0012){ref-type="fn"}      159[^b^](#efs25197-note-0012){ref-type="fn"}   232[^c^](#efs25197-note-0012){ref-type="fn"}   1.46
  Egg (ng/g liquid egg)[^1^](#efs25197-note-0010){ref-type="fn"}   \< 50[^2^](#efs25197-note-0011){ref-type="fn"}   129[^a^](#efs25197-note-0012){ref-type="fn"}   231[^b^](#efs25197-note-0012){ref-type="fn"}   1.79

1 From the Efficacy study (see also Section [3.3.2](#efs25197-sec-0034){ref-type="sec"}).

2 Corresponds to LOQ.

a,b,c Different superscripts within a given row indicate statistical differences (p \< 0.05).

John Wiley & Sons, Ltd

There were significant effects of selenium level and source on the selenium content of the four tissues examined and eggs. In chickens for fattening, the negative control had significantly lower selenium levels in liver, kidney and skin than the standard sodium selenite treatment, which in turn had significantly lower selenium levels than the standard Zn‐[l]{.smallcaps}‐SeMet treatment. The selenium levels in breast muscle were not different between the negative control and the standard sodium selenite treatment, but both were significantly lower than the Zn‐[l]{.smallcaps}‐SeMet treatment.

In both deposition studies performed on chickens for fattening or on laying hens, the level of selenium is higher in the tissues and products in the Zn‐[l]{.smallcaps}‐SeMet treatment compared to control treatment or to sodium selenite treatment.

#### 3.2.4.2. Assessment of the safety for the consumer {#efs25197-sec-0025}

The upper tolerable level (UL) for selenium has been set by the Scientific Committee on Food (European Commission, [2000](#efs25197-bib-0027){ref-type="ref"}) (adults: 300 μg/day; toddlers: 60 μg/day), and used by the FEEDAP Panel in previous assessments of the consumer safety for different selenium compounds.

Data provided by the applicant showed increased tissue deposition of selenium from dietary Zn‐[l]{.smallcaps}‐SeMet compared with sodium selenite (see Table [3](#efs25197-tbl-0003){ref-type="table"}). The FEEDAP Panel has several times expressed its view that SeMet yeast sources would result in similar selenium deposition (EFSA FEEDAP Panel, [2011b](#efs25197-bib-0011){ref-type="ref"},[c](#efs25197-bib-0012){ref-type="ref"}, [2012e](#efs25197-bib-0017){ref-type="ref"}); this view was later extended to the hydroxy‐analogue of SeMet (HMSeBA) (EFSA FEEDAP Panel, [2013a](#efs25197-bib-0018){ref-type="ref"}), to [l]{.smallcaps}‐SeMet (EFSA FEEDAP Panel, [2013b](#efs25197-bib-0019){ref-type="ref"}) and to [dl]{.smallcaps}‐SeMet (EFSA FEEDAP Panel, [2014a](#efs25197-bib-0020){ref-type="ref"}). There is no reason to assume that SeMet from different sources would result in an essentially different deposition pattern in edible tissues/products.

The FEEDAP Panel has previously concluded that the selenium supplementation of feed by selenised yeast, by HMSeBA, by [l]{.smallcaps}‐SeMet or by [dl]{.smallcaps}‐SeMet should be limited to a maximum of 0.2 mg Se/kg feed. Therefore, with respect to consumer safety, the Panel concludes that supplemental selenium from Zn‐ [l]{.smallcaps}‐SeMet should equally be limited to a maximum of 0.2 mg/kg feed.

#### 3.2.4.3. Conclusions on safety for the consumer {#efs25197-sec-0026}

The use of Zn‐[l]{.smallcaps}‐SeMet in animal nutrition is expected to result in a similar increase in selenium deposition in animal tissues/products as that resulting from other sources of SeMet. To ensure consumer safety from consumption of food originating from animals fed Zn‐[l]{.smallcaps}‐SeMet, the FEEDAP Panel concludes that dietary selenium supplementation from the additive should not exceed a maximum of 0.2 mg/kg complete feed, within the maximum total selenium content of 0.5 mg/kg authorised in the EU for complete feedingstuffs.

### 3.2.5. Safety for the user {#efs25197-sec-0027}

#### 3.2.5.1. Effects on the respiratory system {#efs25197-sec-0028}

No specific inhalation toxicity studies for the product under assessment were provided by the applicant.

However, due to the high dusting potential of the formulated additive (maximum determined: 11.0 g/m^3^), an estimation of inhalation exposure was performed.

Taking in consideration the selenium content in dust (average concentration of 4,777 mg/kg), it can therefore be expected that 52.5 mg Se/m^3^ (11.0 g dust/m^3^ × 4,777 mg/kg) will be the selenium content in the dust. The respirable fraction could be estimated to be 93% (see Section [3.1.2](#efs25197-sec-0012){ref-type="sec"}). Thus, the selenium concentration in the respirable dust would then be 49 mg/m^3^ (93% × 52.5 mg Se/m^3^).

Following the above‐described approach for zinc, a value of 59 mg Zn/m^3^ is estimated in the respirable dust.

The estimated value for selenium and for zinc exceeds, respectively, by 3 and by 1 orders of magnitude the most recent internationally accepted proposed thresholds for selenium (0.02 mg/m^3^, set by the Deutsche Forschungsgemeinschaft as maximum concentration in the workplace (Maximale Arbeitsplatz Konzentration, MAK) (DFG, [2012](#efs25197-bib-0006){ref-type="ref"})) and for zinc (2 mg/m^3^, set by the American Conference of Governmental Industrial Hygienists as threshold limit value (TLV) (ACGIH, [2003](#efs25197-bib-0001){ref-type="ref"}), respectively. Consequently, the FEEDAP Panel considers that the additive poses a risk upon inhalation to users.

#### 3.2.5.2. Effects on the eyes and skin {#efs25197-sec-0029}

The applicant submitted an acute skin irritation assay in the rabbit, performed with the formulated additive according to the OECD Guidance 404.[34](#efs25197-note-1039){ref-type="fn"} Availa^®^Se was found to be non‐irritant for the skin of the rabbit.

No specific studies on eye irritation and skin sensitisation were submitted.

#### 3.2.5.3. Conclusions on safety for the user {#efs25197-sec-0030}

The additive is hazardous upon inhalation. Owing to the high dusting potential, persons handling Availa^®^Se are at risk by inhalation.

Availa^®^Se is not an irritant to the skin. In the absence of data, no conclusion on the eye irritation and skin sensitisation can be drawn.

### 3.2.6. Safety for the environment {#efs25197-sec-0031}

It is well documented in the scientific literature that, owing to the specific metabolic fate of organic selenium compounds, which reasonably include the Zn‐[l]{.smallcaps}‐SeMet, significantly more selenium from organic sources than from inorganic sources is retained in the animal body (see Section [3.2.4.1](#efs25197-sec-0024){ref-type="sec"}, Table [3](#efs25197-tbl-0003){ref-type="table"}), and therefore less selenium is expected to be released to the environment.

Therefore, the FEEDAP Panel considers that the use of Zn‐[l]{.smallcaps}‐SeMet in feed does not pose an additional risk to the environment, compared with other sources of selenium for which it will substitute, as long as the maximum authorised content in complete feed is not exceeded. Moreover, the maximum permitted selenium supplementation from organic selenium sources is about half of that for inorganic sources.

Since the contribution of zinc from the additive will be negligible (see also Section [3.2.1](#efs25197-sec-0018){ref-type="sec"}), the environmental impact of zinc needs not to be addressed.

3.3. Efficacy {#efs25197-sec-0032}
-------------

For demonstration of the efficacy of nutritional additives, one study in a single animal species or category, including laboratory animals, is considered sufficient. Zn‐[l]{.smallcaps}‐SeMet is a compound of trace elements not already authorised as a feed additive, a short‐term study is required by to support efficacy (Commission Regulation (EC) No 429/2008; EFSA FEEDAP Panel, [2012a](#efs25197-bib-0013){ref-type="ref"}).

The applicant made for that purpose reference to the studies provided to investigate safety of the additive in chickens for fattening and selenium deposition in chicken and eggs (see also Section [3.2.4](#efs25197-sec-0023){ref-type="sec"}). Also, a third study published by Chantiratikul et al. ([2008a](#efs25197-bib-0004){ref-type="ref"},[b](#efs25197-bib-0005){ref-type="ref"}) could be considered for that purpose.

### 3.3.1. Study in chickens for fattening {#efs25197-sec-0033}

The study has been described above (see Section [3.2.3.1](#efs25197-sec-0021){ref-type="sec"}). The results of this study clearly indicate that at the highest use level of selenium (0.2 mg/kg) from Zn‐[l]{.smallcaps}‐Se‐Met (i) selenium is absorbed, serum selenium increased from 29 in the unsupplemented control to 172 ng/mL, (ii) selenium is deposited in tissues and organs (see Table [3](#efs25197-tbl-0003){ref-type="table"}) and (iii) selenium is incorporated into the functional enzyme GPx (increase in serum from 48 to 1,414 U/mL (see Table [2](#efs25197-tbl-0002){ref-type="table"})).

### 3.3.2. Studies in laying hens {#efs25197-sec-0034}

After a preperiod of 42 days on a basal diet without selenium supplementation, a total of 180 HyLine Brown laying hens (23‐week‐old, mean body weight: 1,728 g) were distributed to five treatments with 12 replicates each.[35](#efs25197-note-1040){ref-type="fn"} The replicate was a cage with three hens. The treatments were (i) no selenium supplementation (basal diet), (ii) supplementation of 0.2 and 0.3 mg Se/kg from Na‐selenite (concentrations confirmed by analysis) and (iii) supplementation of 0.2 and 0.3 mg Se/kg from Zn‐[l]{.smallcaps}‐SeMet. These diets (mash maize soybean meal type diet with 14.8% CP, 12.5% ash, and 11.4 MJ ME/kg) were fed for 60 days.

Performance (body weight, feed intake, feed to egg ratio, egg production) was assessed at day 28 and day 59 while eggs (all eggs pooled/replicate) and blood samples (2 hens/replicate) for analysis of Se and GPx (serum only) were collected on day 59 and day 60 for backup samples. Statistical examination was done by ANOVA (mixed models, Tukey adjustment), differences with a p \< 0.05 were considered significant.

The main results are summarised in Table [4](#efs25197-tbl-0004){ref-type="table"}. No deaths occurred during the study. No significant differences were seen for the performance parameters, except for the ratio feed to egg mass for which an increase was found in the highest dose of Na‐selenite. The Panel suggests that the number of hens per group was not high enough and that the study duration (and that of the depletion period) was not long enough to detect effects on performance by the addition of selenium to a Se‐deficient diet.

###### 

Cumulative data for feed intake, laying rate, egg weight and ratio feed to egg mass, Serum GPx and selenium (24 hens per treatment), and selenium in eggs (all eggs pooled/replicate) on day 59

  Selenium supplemented (mg/kg)                                       0                                               Na‐selenite                                      Availa^®^Se                                                                                                                                
  ------------------------------------------------------------------- ----------------------------------------------- ------------------------------------------------ ----------------------------------------------------------------------------------------- ------------------------------------------------ ------------------------------------------------
  Selenium content (mg/kg)[^1^](#efs25197-note-0013){ref-type="fn"}   0.03                                            0.20                                             0.31                                                                                      0.23                                             0.35
  Feed intake (g/hen per day)                                         113                                             113                                              113                                                                                       114                                              111
  Laying rate (%)                                                     98.4                                            96.8                                             95.3                                                                                      98.1                                             98.3
  Egg weight (g)                                                      60.7                                            61.2                                             59.9                                                                                      60.0                                             59.3
  Ratio feed to egg mass (kg/kg)                                      1.89[^a^](#efs25197-note-0014){ref-type="fn"}   1.91[^a^](#efs25197-note-0014){ref-type="fn"}    1.98[^b^](#efs25197-note-0014){ref-type="fn"}                                             1.91[^a^](#efs25197-note-0014){ref-type="fn"}    1.91[^a^](#efs25197-note-0014){ref-type="fn"}
  Serum Se (ng/mL)                                                    29[^c^](#efs25197-note-0014){ref-type="fn"}     150[^b^](#efs25197-note-0014){ref-type="fn"}     170[^a^](#efs25197-note-0014){ref-type="fn"}, [^b^](#efs25197-note-0014){ref-type="fn"}   181[^a^](#efs25197-note-0014){ref-type="fn"}     195[^a^](#efs25197-note-0014){ref-type="fn"}
  Egg Se (ng/g liquid egg)                                            \< 50                                           129[^d^](#efs25197-note-0014){ref-type="fn"}     157[^c^](#efs25197-note-0014){ref-type="fn"}                                              231[^b^](#efs25197-note-0014){ref-type="fn"}     333[^a^](#efs25197-note-0014){ref-type="fn"}
  GPx (U/mL serum)                                                    100[^b^](#efs25197-note-0014){ref-type="fn"}    1,398[^a^](#efs25197-note-0014){ref-type="fn"}   1,736[^a^](#efs25197-note-0014){ref-type="fn"}                                            1,570[^a^](#efs25197-note-0014){ref-type="fn"}   1,510[^a^](#efs25197-note-0014){ref-type="fn"}

1 Analysed.

a,b,c Different superscripts within a given row indicate statistical differences (p* *\< 0.05).

John Wiley & Sons, Ltd

The selenium levels analysed in serum and egg reflected the dietary selenium concentration. Selenium deposition in the liquid egg indicated the better availability of dietary Zn‐[l]{.smallcaps}‐SeMet compared to sodium selenite. The selenium content per egg was nearly double in the Zn‐[l]{.smallcaps}‐SeMet groups at both dietary levels when compared to the sodium selenite groups. No differences between selenium sources and levels were obtained for the GPx activity in serum, however there was a clear and significant increase compared to control level.

Chantiratikul et al. ([2008a](#efs25197-bib-0004){ref-type="ref"}) compared the effects of sodium selenite and Zn‐[l]{.smallcaps}‐SeMet on plasma selenium concentration and glutathione peroxidase (GPx) activity in the red blood cells (RBC) of laying hens. The supplementation rates were 0.3, 1.0 and 3.0 mg Se/kg feed from both additives. Plasma selenium concentration statistically increased (p \< 0.01) with increasing selenium levels. Plasma Se concentration of hens receiving Zn‐[l]{.smallcaps}‐SeMet supplemented diets was higher (p* *\< 0.05) than that of hens receiving sodium selenite supplemented diets. The Se sources did not dramatically alter GPx activity in RBC. However, GPx activity significantly increased (p* *\< 0.01) with increasing dietary selenium levels. In a subsequent publication of the same study, the authors (Chantiratikul et al., [2008b](#efs25197-bib-0005){ref-type="ref"}) described the effects of both additives on performance and egg selenium concentration in laying hens. Feed consumption/kg egg, egg production, egg weight, Haugh units and eggshell thickness were not affected by sources and levels of selenium (p \> 0.05). Increasing level of dietary selenium significantly increased (p \< 0.05) selenium content in eggs. Zn‐[l]{.smallcaps}‐SeMet markedly increased (p \< 0.05) egg selenium concentrations as compared with sodium selenite. The results indicated that the use of Zn‐[l]{.smallcaps}‐SeMet resulted in higher (p \< 0.05) egg selenium concentrations than that of sodium selenite.

### 3.3.3. Conclusions on efficacy for the target species {#efs25197-sec-0035}

Zn‐[l]{.smallcaps}‐SeMet is an effective source of selenium in chickens for fattening and laying hens; this conclusion is extended to all animal species.

3.4. Post‐market monitoring {#efs25197-sec-0036}
---------------------------

The FEEDAP Panel considers that there is no need for specific requirements for a post‐market monitoring plan other than those established in the Feed Hygiene Regulation[36](#efs25197-note-1041){ref-type="fn"} and Good Manufacturing Practice.

4. Conclusions {#efs25197-sec-0037}
==============

Zn‐[l]{.smallcaps}‐SeMet is a safe source of selenium for chickens for fattening; the conclusion is extended to all animal species.

Selenium from Zn‐[l]{.smallcaps}‐SeMet does not elicit any adverse effects not expected for a selenium compound. The use of Zn‐[l]{.smallcaps}‐SeMet in animal nutrition is expected to result in a similar increase in selenium deposition in animal tissues/products as that resulting from other sources of SeMet. The use of the additive is safe for consumers provided that the maximum selenium supplementation level established for other sources of organic selenium (0.2 mg/kg complete feed) and that the maximum authorised total selenium content (0.5 mg/kg complete feed) are respected.

The additive is hazardous upon inhalation; owing to the high dusting potential, persons handling Availa^®^Se are at risk by inhalation. Availa^®^Se is not an irritant to the skin. In the absence of data, no conclusion on the eye irritation and skin sensitisation can be drawn.

The use of Zn‐[l]{.smallcaps}‐SeMet in feed does not pose an additional risk to the environment, compared with other sources of selenium for which it will substitute, as long as the maximum authorised content in complete feed is not exceeded.

Zn‐[l]{.smallcaps}‐SeMet is an effective source of selenium in chickens for fattening and laying hens; this conclusion is extended to all animal species.

The maximum contribution of zinc in total feed deriving from the use of the additive (\< 0.2 mg Zn/kg feed) is considered low and does not need any safety assessment except for users.

5. Recommendation {#efs25197-sec-0038}
=================

The additive, either as Zn‐[l]{.smallcaps}‐SeMet or as the formulated additive containing Zn‐[l]{.smallcaps}‐SeMet (i.e. Availa^®^Se 1000), should be added to feed via premixture to ensure homogeneous distribution in complete feed.

Documentation provided to EFSA {#efs25197-sec-0039}
==============================

Zinc‐[l]{.smallcaps}‐selenomethionine (Availa Se). August 2016. Submitted by Zinpro Animal Nutrition (Europe), Inc.Zinc‐[l]{.smallcaps}‐selenomethionine (Availa Se). Supplementary information. December 2016. Submitted by Zinpro Animal Nutrition (Europe), Inc.Zinc‐[l]{.smallcaps}‐selenomethionine (Availa Se). Supplementary information. April 2017. Submitted by Zinpro Animal Nutrition (Europe), Inc.Evaluation report of the European Union Reference Laboratory for Feed Additives on the Methods(s) of Analysis for zinc‐[l]{.smallcaps}‐selenomethionine.Comments from Member States.

Abbreviations {#efs25197-sec-0040}
=============

AASatomic absorption spectrometryADMEabsorption, distribution, metabolism and excretionALPalkaline phosphataseAMEapparent metabolizable energyANOVAanalysis of varianceATSDRAgency for Toxic Substances and Disease Registrybwbody weightCASChemical Abstracts ServiceCFUcolony forming unitCPcrude proteinCVcoefficient of variationDFGDeutsche ForschungsgemeinschaftEMAEuropean Medicines AgencyEURLEuropean Union Reference LaboratoryFDAFood and Drug AdministrationFEEDAPEFSA Panel on Additives and Products or Substances used in Animal FeedGPxglutathione peroxidaseHGAAShydride generation atomic absorption spectrometryHPLC‐FLDhigh performance liquid chromatography with fluorescence detectionICP‐AESinductively coupled plasma‐atomic emission spectrometryICP‐MSinductively coupled plasma‐mass spectrometryICP‐OESinductively coupled plasma‐optical emission spectrometryIUPACInternational Union of Pure and Applied ChemistryLOQlimit of quantificationLSDleast significant differencesMAKMaximale Arbeitsplatz KonzentrationOECDOrganisation for Economic Co‐operation and DevelopmentOPA*ortho*‐phthalaldehydePCBpolychlorinated biphenylPCDD/Fpolychlorinated dibenzo‐*p*‐dioxin/dibenzofuranRBCred blood cellsRHrelative humiditySCFScientific Committee on FoodSeMetselenomethionineTEQtoxic equivalentTLVthreshold limit valueULupper tolerable levelWHOWorld Health OrganizationZn‐[l]{.smallcaps}‐SeMetzinc‐[l]{.smallcaps}‐selenomethionine

Annex A -- Executive Summary of the Evaluation Report of the European Union Reference Laboratory for Feed Additives on the Method(s) of Analysis for zinc‐[l]{.smallcaps}‐selenomethionine {#efs25197-sec-1001}
==========================================================================================================================================================================================

 {#efs25197-sec-0041}

In the current application authorisation is sought under article 4(1) for *Zinc‐L‐selenomethionine* under the category/functional group (3b) "nutritional additives"/"compounds of trace elements", according to the classification system of Annex I of Regulation (EC) No 1831/2003. Specifically, authorisation is sought for the use of the *feed additive* for all animal species and categories.

The *feed additive* (*Zinc‐L‐selenomethionine*) is a complexation product of zinc chloride and L‐selenomethionine containing about 63% of L‐selenomethionine and about 20% of zinc. It is to be marketed as a solid preparation, containing a minimum of 0.36% of *Zinc‐L‐selenomethionine*, which corresponds to a minimum of 0.1% of *selenium* and 0.05% of *zinc*; it also contains calcium carbonate, silicon dioxide and vegetable oil as carriers. The *feed additive* is intended to be incorporated into *feedingstuffs* through *premixtures* with a proposed maximum *total selenium* content of 0.5 mg/kg *feedingstuffs* to comply with legal requirements.

For the quantification of *Selenomethionine* in the *feed additive* the Applicant submitted a single‐laboratory validated and further verified method based on high performance liquid chromatography with fluorescence detection (HPLC‐FLD) after pre‐column derivatisation with *ortho*‐phthalaldehyde (OPA). Based on the acceptable performance characteristics presented the EURL recommends for official control this HPLC‐FLD method to quantify *Selenomethionine* in the *feed additive*.

For the quantification of *total selenium* in the *feed additive* the Applicant submitted the official AOAC 2006.03 method designed for the analysis of elements in fertilisers, based on microwave digestion with nitric acid followed by inductively coupled plasma‐optical emission spectrometry (ICP‐OES). In the frame of other dossiers related to selenium containing feed additives the EURL evaluated several alternative single‐laboratory validated and further verified methods, and recommended for official control either inductively coupled plasma‐atomic emission spectrometry (ICP‐AES), or inductively coupled plasma‐mass spectrometry (ICP‐MS) for the quantification of *total selenium* in the *feed additive*.

For the quantification of *total selenium* in *premixtures* and *feedingstuffs* the Applicant did not propose any method for official control. However, the EURL previously evaluated and recommended the CEN method EN 16159:2012 based on hydride generation atomic absorption spectrometry (HGAAS) after microwave digestion with HNO~3~/H~2~O~2~. For the quantification of *total selenium* in *premixtures*, the EURL suggests diluting the *premixtures* samples with ground cereal feed and applying the HGAAS method mentioned above. Based on the performance characteristics available, the EURL recommends for official control the CEN method EN 16159:2012 for the quantification of *total selenium* in *premixtures* and *feedingstuffs*.

For the quantification of *total zinc* in the *feed additive*,*premixtures* and *feedingstuffs* the Applicant submitted the internationally recognised ring‐trial validated method EN 15510 based on inductively coupled plasma‐atomic emission spectrometry (ICP‐AES). Two additional ring‐trial validated methods were previously evaluated by the EURL in the frame of the Zinc group dossiers: EN 15621 based on ICP‐AES after pressure digestion and the Community method based on atomic absorption spectrometry (AAS). Based on the performance characteristics available the EURL recommends for the official control these two CEN methods for the quantification of *total zinc* in the *feed additive*.

Further testing or validation of the methods to be performed through the consortium of National Reference Laboratories as specified by Article 10 (Commission Regulation (EC) No 378/2005) is not considered necessary.

Regulation (EC) No 1831/2003 of the European Parliament and of the Council of 22 September 2003 on additives for use in animal nutrition. OJ L 268, 18.10.2003, p. 29.

Zinpro Animal Nutrition (Europe), Inc. Akkerdistel 2E. 5831 PJ. Boxmeer. The Netherlands.

Patent number EP 1594365 A1. The primary objective of the invention was the development of new compounds intended to enhance the bioavailability and/or increase the stability of seleno‐amino acids. Available online: <https://www.google.com/patents/EP1594365A1?cl=en>

<https://www.federalregister.gov/documents/2014/08/21/2014-19831/zinpro-corp-filing-of-food-additive-petition-animal-use>

FEED dossier reference: FAD‐2016‐0056.

Commission Regulation (EC) No 429/2008 of 25 April 2008 on detailed rules for the implementation of Regulation (EC) No 1831/2003 of the European Parliament and of the Council as regards the preparation and the presentation of applications and the assessment and the authorisation of feed additives. OJ L 133, 22.5.2008, p. 1.

The full report is available on the EURL website: <https://ec.europa.eu/jrc/sites/jrcsh/files/finrep-fad-2016-0056-zinc-selenomethionine.pdf>

Technical Dossier/Section II.

Technical Dossier/Section II/Annexes II‐32 to II‐36.

Technical Dossier/Section II/Annexes II‐37 to II‐41.

These values are not consistent with the limit of quantification of the analytical method (LOQ: 0.1 mg/kg). Technical Dossier/Supplementary information.

Directive 2002/32/EC of the European Parliament and of the Council of 7 May 2002 on undesirable substances in animal feed. OJ L 140, 30.5.2002, p. 10.

Technical Dossier/Section II/Annex II‐53.

Dossier/Section II/Annexes II‐1 to II‐5.

Technical Dossier/Section II/Annexes II‐10 to II‐15.

Assuming that the LOQs for the analysis of undesirable substances in the additive are the same as those for the active compound (see footnote 8), these values are found not to be consistent with a LOQ of 0.1 mg/kg for Cd and Hg and of 25 mg/kg for F.

Technical Dossier/Section II/Annexes II‐21 to II‐25.

Technical Dossier/Section II/Annexes II‐26 to II‐28.

Technical Dossier/Supplementary information.

Technical Dossier/Section II/Annex II‐29.

Technical Dossier/Section II/Annex II‐30.

Technical Dossier/Section II/Annex II‐31.

Zinc in one batch was not determined.

This section has been amended following the confidentiality claims made by the applicant.

Technical Dossier/Section II/Annexes II‐48 and II‐49.

Technical Dossier/Section II/Annex II‐50.

Technical Dossier/Section II/Annex II‐51.

Technical Dossier/Section II/Annex II‐52.

Considering the maximum supplementation rate of the formulated additive (i.e. 200 mg Availa^®^Se 1,000 per kg complete feed), the contribution of zinc from the additive to the total dietary zinc would be below 0.2 mg/kg.

Technical Dossier/Section III/Annex III_1.

Some animals were kept for 37 days.

Red blood cells, packed cell volume, haemoglobin, white blood cell, lymphocytes, neutrophil granulocytes, monocytes, mean corpuscular haemoglobin, mean corpuscular haemoglobin concentration, mean corpuscular volume.

Albumin, albumin/globulin ratio, total protein, alkaline phosphatase, alanine aminotransferase, aspartate aminotransferase, lactate dehydrogenase, gamma‐glutamyl transferase, glutamate dehydrogenase, creatinine, creatine phosphokinase, bilirubin, glucose, triglycerides, cholesterol, urea, Ca, P, K, Na, Cl.

Technical Dossier/Section III/Annex_III_3.

Technical Dossier/Section IV/Annex_IV_4\_2.

Regulation (EC) No 183/2005 of the European Parliament and of the Council of 12 January 2005 laying down requirements for feed hygiene. OJ L 35, 8.2.2005, p. 1.
